| Name: | Baricitinib Impurity 5 |
| Catalogue No. | VL3190005 |
| CAS No. | N/A |
| Molecular Formula | C26H29N11O4S2 |
| Molecular Weight | 623.71 |
| Status | In-Stock |
| IUPAC Name | 2-(3-(4-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
| Description | Baricitinib Impurity 5 ( CAS No: N/A ) or 2-(3-(4-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile is an associate impurity of Barictinib. Baricitinib could be a JAK1 and JAK2 substance and are used as a promising treatment for arthritis. |
| References | Seelam*, Dr. Mohan, et al. “Development and Validation of a Stability Indicating Related Substances of Baricitinib by RP-HPLC and Its Degradation.” International Journal of Management and Humanities, vol. 4, no. 2, Oct. 2019, pp. 4–9, https://doi.org/10.35940/ijmh.a0369.104219. |
